dermaviduals® DMS
  Menu KOKO - the company >> news imprint sitemap German
 

New medicinal product

 
 

Our global partner, High Grade Pharmaceutical Co., Ltd., has applied for a patent "Drug having Steroids and Fatty Compound" in Taiwan, China und USA at the beginning of the year 2017. The first product of the patent, based on DMS technology and Fluticasone Propionate (INN), a pharmaceutical drug similar to hydrocortisone, was developed with KOKO and launched in Taiwan recently. Among others it is recommended for acute, inflamed cases of neurodermatitis. Advantage: After fast remission of the skin reactions the treatment can be continued subsequently by cosmetic prevention, e.g. with DMS base cream High Classic Plus. For the first time pharmaceutical treatment is combined with sustained corneotherapy by means of lamellar creams.

Lamellar Fluticasone cream

Lamellar Fluticasone cream

 
 
 
   
 
 
 
Please use the reader-view for mobile terminals.
If there are any questions, do not hesitate to contact us via koko@dermaviduals.de .
This applies to any misprint or other relevant mistakes on this page too.
© Copyright Kosmetik Konzept KOKO GmbH & Co. KG, Leichlingen, www.dermaviduals.de
Revision: 15.10.2018